Search

Union World Conference on Lung Health 2020

The 51st Union World Conference on Lung Health – Advancing Prevention – will take place as a virtual conference from 20–24 October 2020.

Wednesday, 21 October 2020
SYMPOSIUM 11:00–12:20 CET
Tests for the detection of TB infection – tuberculin skin test vs interferon-gamma release assays
Speakers: Morten Ruhwald, FIND
ORAL ABSTRACTS 12:30–13:50 CET
Innovative TB diagnostics – Moderator: Morten Ruhwald, FIND
SYMPOSIUM 12:30–13:50 CET
Updating World Health Organization TB screening guidelines: evidence reviews of the yield, tools and costs of screening
12:55–13:05: Computer Aided Detection (CAD) Solutions for Pulmonary Tuberculosis: what is their performance in screening and diagnostic triage settings? Sandra Kik, FIND
SYMPOSIUM 16:30–17:50 CET
Is TB elimination in the European Region a realistic goal?
16:55–17:05: Translational research and new tools in the pipeline to eliminate TB in low burden countries, Morten Ruhwald, FIND
Thursday, 22 October 2020
SYMPOSIUM 11:00–12:20 CET
Detecting TB among people living with HIV: updated options with updated guidance
11:35–11:45: Molbio diagnostics Truenat™ MTB, MTB Plus and MTB-RIF: lessons learned from India, Sanjay Sarin, FIND India
ORAL ABSTRACT SESSION 12:30–13:50 CET
TB Xpert in LMICS: Ensuring quality and quantity
12:51:–12:59: Mentoring TB labs for improving and sustaining QMS implementation and ISO 15189 accreditation: Experiences from India, Tarak Shah, FIND India
SYMPOSIUM 15:00–16:20 CET
Improving access to laboratory-based diagnosis for young children — recent advances using stool and urine as alternative sample types
15:15–15:25: Utility of stool samples for microbiological confirmation of TB in children, Pamela Nabeta, FIND
UNION LATE-BREAKER SESSION on COVID-19 15:00–16:20 CET
Comparative evaluation of the clinical accuracy of SARS-CoV-2 serological rapid diagnostic tests and manual ELISAs
Speakers: Jilian Sacks, FIND
SYMPOSIUM 16:30–17:50 CET
Advancing a prevention research agenda for TB
16:47–16:59: Diagnosing TB Infection (TBI) to prevent TB: an overview of the landscape of TBI and incipient TB tests, Morten Ruhwald, NDWG
MEET THE EXPERT 18:15–19:15 CET
The external quality assessment of Cepheid GeneXpert® diagnostic assays, Heidi Albert, FIND South Africa, and Tarak Shah, FIND India
FIND & NDWG SATELLITE SESSION 18:15–19:45 CET

Agenda

Advancements in the TB diagnostics pipeline: FIND and NDWG annual symposium
Friday, 23 October 2020
TB SCIENCE 15:00–16:30 CET
What is new in drug-resistance detection: plenary session
15:03–15:23: Sequencing to support DR TB treatment decisions: a new landscape of options, Timothy Rodwell, FIND
FIND & GLOBAL FUND SATELLITE SESSION 18:15–19:45 CET

Agenda

Testing to turn the COVID-19 pandemic—the opportunity for TB
COMMUNITY CONNECT SESSIONS (website)
Adapting TB advocacy in times of COVID-19: 20:00–20:45 CET (Flyer)
Moderator: Karishma Saran, FIND
Saturday, 24 October 2020
ORAL ABSTRACTS 12:30–13:50 CET
Diagnostic assay quality and accuracy

  • Comparative analytical evaluation of four centralized platforms for the detection of M. tuberculosis complex and detection of resistance to rifampicin and isoniazid, Margaretha De Vos, FIND
  • Diagnostic accuracy of the Molbio Truenat TB and RIF-resistance assays in the intended setting of use, Adam Penn-Nicholson, FIND
  • Diagnostic accuracy of the Xpert MTB/XDR assay for isoniazid and second-line drug resistance detection, Adam Penn-Nicholson, FIND
ePOSTER PRESENTATIONS starting at 10:00 CET
  • Emerging trends in private notifications in India: Experiences from the Joint Effort for Elimination of Tuberculosis (JEET) project, Aakshi Kalra, FIND India
  • Investing in additional resources to catalyse access to TB care in private sector. An experience from Southern India, Vaibhav Ghule, FIND India